First Monoclonal Antibody for Multiple Myeloma Receives FDA Approval November 20, 2015December 14, 2022 Alexandra Mulvey
Nivolumab Becomes First FDA-Approved Checkpoint Blockade for Kidney Cancer November 24, 2015December 14, 2022 Arthur N. Brodsky, PhD
Second Antibody FDA-Approved Against Multiple Myeloma December 1, 2015December 14, 2022 Arthur N. Brodsky, PhD
Immunotherapy Shines at ASH and ESMO IO Conferences December 15, 2017December 14, 2022 Arthur N. Brodsky, PhD
ASH18 Preview: Blood Cancer Immunotherapy Developments November 30, 2018December 14, 2022 Arthur N. Brodsky, PhD